Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights

Go back to Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights

Oncolytics Biotech (ONCY) Posts Wider Q4 Loss

March 3, 2022 4:02 PM EST

Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.49), $0.39 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

... More